bioRxivMicrobiology
Inhibition of Phosphodiesterase 12 results in Antiviral Activity against several RNA Viruses including SARS-CoV-2.
P. Karayiannis, M. Thursz, F. Sadiq, J. Tree, D. Beasley, W. Dejnirattisai, J. Mongkolsapaya, G. Screaton, M. Wand, M. Elmore, C. Miles, I. Matthews, H. Thomas
Abstract
Phosphodiesterase 12 (PDE12) is a negative regulator of the type 1 interferon (IFN) response and here we show that PDE12 inhibitors (lead compounds 63 and 17) are associated with increased RNAseL activity, are well tolerated at the therapeutic range and inhibit, both in vitro and in vivo, the replication of several RNA viruses including hepatitis C virus (HCV), dengue virus (DENV), West Nile Virus (WNV) and SARS-CoV-2.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Diverse Strategies Utilized by Coronaviruses to Evade Antiviral Responses and Suppress Pyroptosis
- Discovery of five HIV nucleoside analog reverse-transcriptase inhibitors (NRTIs) as potent inhibitors against the RNA-dependent RNA polymerase (RdRp) of SARS-CoV and 2019-nCoV
J. Sun·bioRxiv·Nov 1, 2020
- The in vitro antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2
C. Q. Sacramento, N. Fintelman-Rodrigues, … T. M. L. Souza·bioRxiv·Jun 15, 2020
- Interaction of SCoV-2 NSP7 or NSP8 alone with NSP12 causes constriction of the RNA entry channel: Implications for novel RdRp inhibitor drug discovery
Deepa Singh, Tushar Kushwaha, … Krishna Kishore Inampudi·bioRxiv·Jul 26, 2023
- Long-chain polyphosphates impair SARS-CoV-2 infection and replication: a route for therapy in man
Veronica Ferrucci, Dae-Young Kong, … Massimo Zollo·Science SignalingPeer-reviewed·Jul 6, 2021
- Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase
M. Chien, T. K. Anderson, … Jingyue Ju·bioRxiv·Mar 12, 2020